BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce ...
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral ...
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing ...
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: QLGN) (the “Company”) today announced that on September 11, ...
Range Impact Announces Application to Uplist to the OTCQB Venture Market
CLEVELAND, OHIO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a ...